Kellum JA, Romagnani P, Ashuntantang G, Ronco C, Zarbock A, Anders HJ. Acute kidney injury. Nat Rev Dis Primers. 2021;7:52.
Bellomo R, Kellum JA, Ronco C. Acute kidney injury. Lancet. 2012;380:756–66.
Basile DP. The endothelial cell in ischemic acute kidney injury: implications for acute and chronic function. Kidney Int. 2007;72:151–6.
Raup-Konsavage WM, Wang Y, Wang WW, Feliers D, Ruan H, Reeves WB. Neutrophil peptidyl arginine deiminase-4 has a pivotal role in ischemia/reperfusion-induced acute kidney injury. Kidney Int. 2018;93:365–74.
de Oliveira RC, Wilson SE. Fibrocytes, wound healing, and corneal fibrosis. Invest Ophthalmol Vis Sci. 2020;61:28.
PubMed PubMed Central Google Scholar
Talbott HE, Mascharak S, Griffin M, Wan DC, Longaker MT. Wound healing, fibroblast heterogeneity, and fibrosis. Cell Stem Cell. 2022;29:1161–80.
CAS PubMed PubMed Central Google Scholar
Lynch MD, Watt FM. Fibroblast heterogeneity: implications for human disease. J Clin Invest. 2018;128:26–35.
PubMed PubMed Central Google Scholar
Tiggelman AMB, Boers W, Lintherst C, Brand HS, Sala M, Chamuleau RAF. Interleukin-6 production by human liver (myo)fibroblasts in culture - evidence for a regulatory role of lps, Il-1-beta and Tnf-alpha. J Hepatol. 1995;23:295–306.
Travers JG, Kamal FA, Robbins J, Yutzey KE, Blaxall BC. Cardiac fibrosis: the fibroblast awakens. Circ Res. 2016;118:1021–40.
CAS PubMed PubMed Central Google Scholar
Aggarwal S, Wang ZX, Pacheco DRF, Rinaldi A, Rajewski A, Callemeyn J, et al. SOX9 switch links regeneration to fibrosis at the single-cell level in mammalian kidneys. Science. 2024;383:eadd6371.
CAS PubMed PubMed Central Google Scholar
Humphreys BD, Bonventre JV. Mesenchymal stem cells in acute kidney injury. Annu Rev Med. 2008;59:311–25.
Zhou D, Fu H, Xiao L, Mo H, Zhuo H, Tian X, et al. Fibroblast-specific beta-catenin signaling dictates the outcome of AKI. J Am Soc Nephrol. 2018;29:1257–71.
CAS PubMed PubMed Central Google Scholar
Bendavid Y, Giddens EB, Letwin K, Bernstein A. Erythroleukemia induction by Friend murine leukemia-virus - insertional activation of a new member of the Ets gene family, Fli-1, closely linked to C-Ets-1. Gene Dev. 1991;5:908–18.
Zhao XH, Bartholdy B, Yamamoto Y, Evans EK, Alberich-Jordà M, Staber PB, et al. PU.1-c-Jun interaction is crucial for PU.1 function in myeloid development. Commun Biol. 2022;5:961.
CAS PubMed PubMed Central Google Scholar
Li GL, Hao WK, Hu WX. Transcription factor PU.1 and immune cell differentiation (Review). Int J Mol Med. 2020;46:1943–50.
Ralvenius WT, Andresen JL, Huston MM, Penney J, Bonner JM, Fenton OS, et al. Nanoparticle-mediated delivery of anti-PU.1 siRNA via localized intracisternal administration reduces neuroinflammation. Adv Mater. 2024;36:e2309225.
Liu QM, Yu JJ, Wang LH, Tang YL, Zhou Q, Ji SH, et al. Inhibition of PU.1 ameliorates metabolic dysfunction and non-alcoholic steatohepatitis. J Hepatol. 2020;73:361–70.
Wohlfahrt T, Rauber S, Uebe S, Luber M, Soare A, Ekici A, et al. PU.1 controls fibroblast polarization and tissue fibrosis. Nature. 2019;566:344.
CAS PubMed PubMed Central Google Scholar
Zhang Y, Tang PM, Niu Y, Garcia Cordoba CA, Huang XR, Yu C, et al. Long non-coding RNA LRNA9884 promotes acute kidney injury via regulating NF-κB-mediated transcriptional activation of MIF. Front Physiol. 2020;11:590027.
PubMed PubMed Central Google Scholar
Coca SG, Singanamala S, Parikh CR. Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. Kidney Int. 2012;81:442–8.
Xue JL, Daniels F, Star RA, Kimmel PL, Eggers PW, Molitoris BA, et al. Incidence and mortality of acute renal failure in medicare beneficiaries, 1992 to 2001. J Am Soc Nephrol. 2006;17:1135–42.
Venkatachalam MA, Weinberg JM, Kriz W, Bidani AK. Failed tubule recovery, AKI-CKD transition, and kidney disease progression. J Am Soc Nephrol. 2015;26:1765–76.
CAS PubMed PubMed Central Google Scholar
Maremonti F, Meyer C, Linkermann A. Mechanisms and models of kidney tubular necrosis and nephron loss. J Am Soc Nephrol. 2022;33:472–86.
CAS PubMed PubMed Central Google Scholar
Zuk A, Bonventre JV. Acute kidney injury. Annu Rev Med. 2016;67:293–307.
CAS PubMed PubMed Central Google Scholar
Leaf DE, Rajapurkar M, Lele SS, Mukhopadhyay B, Boerger EAS, Mc Causland FR, et al. Iron, hepcidin, and death in human AKI. J Am Soc Nephrol. 2019;30:493–504.
CAS PubMed PubMed Central Google Scholar
Li X, Yuan F, Xiong Y, Tang Y, Li Z, Ai J, et al. FAM3A plays a key role in protecting against tubular cell pyroptosis and acute kidney injury. Redox Biol. 2024;74:103225.
CAS PubMed PubMed Central Google Scholar
Lin QS, Li S, Jiang N, Jin HJ, Shao XH, Zhu XY, et al. Inhibiting NLRP3 inflammasome attenuates apoptosis in contrast-induced acute kidney injury through the upregulation of HIF1A and BNIP3-mediated mitophagy. Autophagy. 2021;17:2975–90.
Wynn TA, Ramalingam TR. Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat Med. 2012;18:1028–40.
CAS PubMed PubMed Central Google Scholar
Sakai N, Wada T, Yokoyama H, Lipp M, Ueha S, Matsushima K, et al. Secondary lymphoid tissue chemokine (SLC/CCL21)/CCR7 signaling regulates fibrocytes in renal fibrosis. Proc Natl Acad Sci USA. 2006;103:14098–103.
CAS PubMed PubMed Central Google Scholar
Baues M, Dasgupta A, Ehling J, Prakash J, Boor P, Tacke F, et al. Fibrosis imaging: current concepts and future directions. Adv Drug Deliv Rev. 2017;121:9–26.
CAS PubMed PubMed Central Google Scholar
Kinchen J, Chen HH, Parikh K, Antanaviciute A, Jagielowicz M, Fawkner-Corbett D, et al. Structural remodeling of the human colonic mesenchyme in inflammatory bowel disease. Cell. 2018;175:372–86.e17.
CAS PubMed PubMed Central Google Scholar
West NR, Hegazy AN, Owens BMJ, Bullers SJ, Linggi B, Buonocore S, et al. Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease. Nat Med. 2017;23:579–89.
CAS PubMed PubMed Central Google Scholar
Huang B, Chen Z, Geng L, Wang J, Liang H, Cao Y, et al. Mucosal profiling of pediatric-onset colitis and IBD reveals common pathogenics and therapeutic pathways. Cell. 2019;179:1160–76.e24.
Komatsu N, Takayanagi H. Mechanisms of joint destruction in rheumatoid arthritis - immune cell-fibroblast-bone interactions. Nat Rev Rheumatol. 2022;18:415–29.
Zhang Y, Huang H, Kong Y, Xu C, Dai L, Geng X, et al. Kidney tubular transcription co-activator, Yes-associated protein 1 (YAP), controls the expression of collecting duct aquaporins and water homeostasis. Kidney Int. 2023;103:501–13.
Estrela GR, Freitas-Lima LC, Budu A, Arruda AC, Perilhao MS, Fock RA, et al. Chronic kidney disease induced by cisplatin, folic acid and renal ischemia reperfusion induces anemia and promotes GATA-2 activation in mice. Biomedicines. 2021;9:769.
Comments (0)